Background: Prime Minister's National Health Programme (PMNHP) is a publically funded cashless scheme at point of service, which was initiated in December 2015 to provide access to universal healthcare to people living below poverty line for indoor secondary and tertiary healthcare services for priority diseases in Pakistan. Objective: Our study aimed to compare prices of PMNHP districts packages, compare PMNHP with average payments made to healthcare providers by various health insurance companies, and compare prices among PMNHP itself, public sector not supported by the programme, and private healthcare not supported by the programme in Islamabad Methods: We conducted this comparative descriptive cross sectional study. For first two objectives, we collected secondary data, and for the third objective, we did convenient sampling of the treated patient (n-158) from PMNHP, public and private hospitals for selected diseases.
Introduction
Access to universal healthcare for people living below poverty line is not easy in number of developing countries due to merely nonexistence of health insurance system for universal coverage. WHR 2000 outlined functions for improving health system that includes arrangement and allocation health finances and good governance or government stewardship (1) . Implementation of targeted interventions for marginalized people are significant in Pakistan, where no compulsory health insurance (2) . Insurance schemes have meager share in healthcare financing (3) . In Pakistan; Out of Pocket spending is main source for healthcare financing (4) . To extend access to universal healthcare to people living below poverty line, Prime Minister's National Health Insurance Program (PMNHP) was launched on 31st December 2015 in phased manner (5) . In low income countries, healthcare services accessible to merely 11% of people living below poverty line due to financial constraints (6, 7) . In several under developed and developing countries out of pocket spending on purchase of healthcare products exceed more than 50% of total healthcare service expenses (8) . Numbers of countries have designed their own health insurance model for healthcare financing to provide universal health coverage and financial risk protection. German, state owned healthcare insurance scheme provides coverage to almost 85% of their citizens without any preexisting condition (9) . Japanese National Health insurance provides financial coverage to not eligible population for Employees Health Insurance.10,11 US, Medicaid, Indian Vajpayee Arogyashree Scheme (VAS) for tertiary care, (7, 16) and Rashtriya Swasthya Bima Yojna (RSBY) for secondary care(12) are designed for low income eligible people. British, National Health Service (NHS) (9) and Sri Lanka exclusively finances healthcare service through public revenue. (16) Iran has introduced Medical Insurance Fund (IMIF), on 50 percent co-payment basis (17, 18) . Pakistan is confronting number of challenges as far as its healthcare financing and resource allocation are concerned. Major issue is affordability of low income families to face catastrophic healthcare expenses (19) . PMNHP was launched for eligible families, living with daily income of $2 per day and below were identified from the Benazir Income Support Program (BISP) survey 2010 database (2, 5) were issued health cards up to PKR. 50,000 (US$477) credit limits. In addition up to Rs 300,000 to cover treatment for seven priority diseases. Program was planned to start in phased manner in 23 selected districts, 3.2 million families are being benefited. Prior to extend program in remaining districts as Phase II, it was felt to evaluate the program in terms of price comparison with healthcare provider payments made by various other private insurance companies, and health products price at public and private healthcare facilities for treatment and management of selected diseases and procedures. Our objectives were: (a) to compare price of PMNHP districts packages for treatment and management of selected diseases and procedures, (b) to compare healthcare providers' payments made by various health insurance companies in country with PMNHP packages for treatment and management of selected diseases and procedures, and (c) to compare price for treatment and management of selected diseases and procedures at public and private healthcare facilities of Islamabad District with PMNHP packages. Methodology Comparative Descriptive Cross Sectional Quantitative Study design was adopted. Selected diseases and procedures were Normal delivery (NVD), Caesarian Section (CS), Cholecystectomy (Chole), Diabetes Mellitus (DM) and Coronary Angioplasty (Angio). For objectives (a) and (b) secondary data were used. While for Objective (c) convenient sampling was done to select patient treated from selected diseases and procedures from PMNHP, public and private hospitals. Total 158 treated patients were selected, 30 each from NVD and CS, 31 each from Chole and DM and 36 from Angio. Primary data were collected by trained data collectors through survey questionnaire prepared according to WHO Guidelines 2002 (20) . Similarly, for objective (a), relevant authorities were approached for secondary data regarding district PMNHP packages and list of enrolled clientele along with clientele who utilized services of PMNHP up to 15th Oct 2016. For objective (b), various Insurance companies were approached for provision of data regarding average price paid to healthcare provider during year 2016 for treatment of selected diseases/procedures. For objective (c), data were collected from living treated patients from PMNHP, p u b l i c a n d p r i v a t e h o s p i t a l s t h r o u g h s u r v e y questionnaire by trained data collectors. We compared the price of various districts PMNHP packages, payments made to healthcare facilities in Pakistan by various health insurance companies, and price paid by treated patients under study at public and private sector hospitals in Islamabad for purchase of health products for treatment of selected diseases/procedures. PMNHP district packages and comparison between PMNHP packages and average payments made to healthcare providers by various health insurance companies in year 2016 for selected disease and procedures were cross tabulated. Price comparison among PMNHP, Public(OOPS) and Private healthcare providers were conducted through one way analysis of variances (ANOVA) to assess the significance of the difference among groups and within groups. Assumptions regarding normality and homogeneity of variance were tested. Pairwise multiple comparisons were generated by using Tuckey's honestly significant difference (HSD) post hoc criterion for significance. Table 1 represents price comparison of PMNHP district packages at empanelled healthcare facilities for treatment and management of selected diseases and procedures. For NVD package RYK had the lowest cost. In case of CS and Chole prices were almost same. In management of DM (both insulin and non insulin dependent), Mzd had the lowest and Qta had the highest all inclusive costs. Among empanelled healthcare setups of PMNHP, facilities for angioplasty were only available at ICT. Table 2 , shows comparison of price paid by various insurance companies to healthcare providers for general w a r d a n d P M N H P p a c k a g e s f o r s e l e c t e d diseases/procedures during year 2016. PMNHP's packages for selected diseases and procedures are on lower side as compared to other private insurance companies for year 2016. Table 4 ; after assuming homogeneity of variances, Table  5 ; an analysis of variances were performed for each category. ANOVA showed differences in price were significant for management of NVD. PMNHP for NVD was found more expensive than Pub(OOPS) and Private Table 6 , Post hoc analysis using Tuckey's HSD criterion for significance indicated that mean difference was not significant in comparison of PMNHP with Pvt. Price comparison for CS and Chole were significant. Tuckey's HSD criterion for significance indicated that mean differences were significant. Mean cost of PMNHP both for CS and Chole were found on higher side as compared to Pub(OOPS). PMNHP were cost beneficial as compared to private(OOPS). Discussion Every country on globe has designed a customized version healthcare system in an attempt to provide universal access to healthcare services. Pricing of healthcare products vary among regions and countries. PMNHP is a public funded health insurance scheme that is free of cost at point of service delivery. Program provides universal healthcare access to people living below poverty line (5) . Program design features were adopted from US Medicaid(6) and Indian models, VAS (7) and RSBY (15) for tertiary and secondary care respectively. PMNHP district wise package comparison has revealed almost same rates were offered by the healthcare facilities. For NVD and CS, program offered the same price PKRs15000 to discourage un-indicated caesarian sections and encourage healthcare facilities to opt for normal delivery. Same trend was seen in management of all other selected diseases/procedures. In comparison of the program with other private health insurance scheme, the average lowest payment made to healthcare providers by any company is almost double with matching LoS at hospital of same category. Like Chole, PMNHP package costs PKRs30000 with LoS 3 days while lowest average price by any insurance company is PKRs77522 with LoS 3.31 days. Prices at private outfits through out of pocket spending are also not compatible with the program. However, at public healthcare facilities there is significantly lower cost effects were depicted. At public sector, major part of fixed and variable cost was bored by government exchequer, like consultancies, cost of hospitalization and other costs. Patients spend for only non-available medicine and other surgical supplies through OOPS. If these fixed and variable costs incurred at public Healthcare facilities are added, then total price of treatment may rise to competitive level. It was considered that program seems to be fairly priced through selected state owned insurance company. US, Medicaid(6) provides access to universal healthcare to eligible low-income citizen. However, States may charge premiums as cost sharing in form of co-payments and co-insurance. Even then, many Medicaid enrollees are facing difficulties to find Healthcare providers, as they were denied treatment due to complex administrative procedures and low imbursement rates. A conservative estimation, based on reimbursements of claims on account of services and fees, revealed that US healthcare products prices may be considered much higher as compared to other developed countries. IFHP 2015 report(21) revealed average prices in US for NVD, CS and coronary angioplasty ranges from $ 8011, CS $11401, Angio $15549. In Australia prices were for ND $5312, CS $7901 and Angio costs $11164. While in South Africa prices were NVD $1271, CS $2192 and Angio $6510. In 2016, NHS UK healthcare product prices22 with CC Score^ Zero were for NVD and CS £"1755, Chole £2595, Angio £2554 and DM £170.5 per day. In Indian VAS program, empanelled hospitals do not entertain direct patient, instead they arrange periodic health camps to screen the eligible patients for treatment. PMNHP may be considered more clients friendly in comparison to US Medicaid(6) and Indian VAS (7) programs. Neither Indian VAS program(23) nor RSBY(24) provide access to healthcare services to people living below poverty line for any disease under study except coronary angioplasty that cost INR* 70000 in 2016 VAS packages(23). However in India, at private healthcare provider costs for NVD, CS and Angio INR 20000, 25000 and 120000 respectively for general ward. While at public healthcare settings OOPS for NVD and CS were approximately INR 2000 and 6000 respectively. Conclusion PMNHP district wise packages are almost same among and for all the districts. Program is fairly and competitively priced against public and private healthcare providers, and private health insurance healthcare provider payments. PMNHP design features may be used to extend program in other districts. Limitations Patients who are utilized public or private healthcare services, did not have actual accounting of cost, they relied on recall or memory. Cost effectiveness analysis in terms of improved health status of study population could not be done, and restricted to price comparison analysis.
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